By Prof. Dr. Lieven Annemans, expert-trainer of the Health Economics for Non-Health-Economists course, Critical New HTA Developments in Europe: Challenges & Solutions and the Online Self-Study Programme - Basics of Health Economics.
QALY stands for Quality Adjusted Life Year. The QALY is commonly used in health economic evaluations as a means of quantifying the health effect of a medical intervention or a prevention program and ultimately to help payers allocate healthcare resources.
The QALY can be calculated using the following formula which assumes a utility value (quality of life) between 1 = perfect health and 0 = dead:
Years of Life x Utility Value = #QALYs
This means:
In cost-effectiveness studies (or: health economic evaluations) the QALY is used to quantify the effectiveness of, for instance, a new medicine versus the current one. In other words, the current standard of care is taken as the baseline, and the QALYs gained from the new (improved) intervention are counted in addition.
In order to be able to compare QALY gains across diseases and therapeutic areas, a comparative scale has been developed to determine the quality of life (utility level) an individual has with a particular disease.
The beauty of the QALY therefore is that it allows you to compare the health effect of a new cancer therapy with the health effect of a new anti-depressant (or with any other medical intervention).